Intrinsic cytotoxicity and reversal of multidrug-resistance by monensin in KB parent and MDR cells

Y. H. Ling, W. Priebe, Roman Perez-Soler

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Results presented in this study indicate that monensin, a Na+/H+ gradient ionophore, is by itself a potent inhibitor of proliferation of both KB parent and KB/multidrug resistant (MDR) cells. By MTT assay, the ID50 of monensin against both cell lines after a 72 h drug exposure was 0.2±0.04 μg/ml. Following a 1 h exposure of KB parent and KB/MDR cells to 0.1-10 μg/ml- monensin, [3H]thymidine, [3H]uridine, [3H]leucine incorporation into DNA, RNA, and proteins, respectively, was not inhibited, thus suggesting that the mechanism of cytotoxicity of monensin may not be mediated by a direct effect on macromolecular synthesis. In the presence of subtoxic concentrations of monensin (0.05-0.1 μg/ml), the ID50 of doxorubicin against KB/MDR cells after a 72 h drug exposure was reduced from >100 μg/ml to 45 and 18 μg/ml, respectively, while the presence of monensin did not significantly alter doxorubicin cytotoxicity against KB parent cells. In 1 h experiments, the presence of monensin (5 μg/ml) increased the intracellular accumulation of doxorubicin in KB/MDR cells by about two- to threefold but not in KB parent cells. Monensin also markedly reduced doxorubicin efflux from KB/MDR cells. Under the same conditions, monensin enhanced the cellular uptake and cytotoxicity of daunorubicin and hydroxyrubicin in KB/MDR cells but not of the lipophilic anthracycline annamycin. By alkaline elution technique, monensin (5 μg/ml) alone did not induce DNA damage in either KB parent or KB/MDR cells after 1 h of incubation and did not enhance doxorubicin-induced DNA damage in KB parent cells, whereas it significantly increased doxorubicin induced DNA double-strand breaks in KB/MDR cells. Our results indicate that reversal of MDR by monensin may be due to facilitation of drug transport and subsequent enhancement of DNA damage in MDR cells.

Original languageEnglish (US)
Pages (from-to)971-977
Number of pages7
JournalInternational Journal of Oncology
Volume3
Issue number5
StatePublished - 1993
Externally publishedYes

Fingerprint

Monensin
Multiple Drug Resistance
KB Cells
Doxorubicin
DNA Damage
Pharmaceutical Preparations
Daunorubicin
Uridine
Anthracyclines
Ionophores
Leucine
Thymidine
RNA

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Intrinsic cytotoxicity and reversal of multidrug-resistance by monensin in KB parent and MDR cells. / Ling, Y. H.; Priebe, W.; Perez-Soler, Roman.

In: International Journal of Oncology, Vol. 3, No. 5, 1993, p. 971-977.

Research output: Contribution to journalArticle

@article{68a32ee83293466b8f85a82306b14e94,
title = "Intrinsic cytotoxicity and reversal of multidrug-resistance by monensin in KB parent and MDR cells",
abstract = "Results presented in this study indicate that monensin, a Na+/H+ gradient ionophore, is by itself a potent inhibitor of proliferation of both KB parent and KB/multidrug resistant (MDR) cells. By MTT assay, the ID50 of monensin against both cell lines after a 72 h drug exposure was 0.2±0.04 μg/ml. Following a 1 h exposure of KB parent and KB/MDR cells to 0.1-10 μg/ml- monensin, [3H]thymidine, [3H]uridine, [3H]leucine incorporation into DNA, RNA, and proteins, respectively, was not inhibited, thus suggesting that the mechanism of cytotoxicity of monensin may not be mediated by a direct effect on macromolecular synthesis. In the presence of subtoxic concentrations of monensin (0.05-0.1 μg/ml), the ID50 of doxorubicin against KB/MDR cells after a 72 h drug exposure was reduced from >100 μg/ml to 45 and 18 μg/ml, respectively, while the presence of monensin did not significantly alter doxorubicin cytotoxicity against KB parent cells. In 1 h experiments, the presence of monensin (5 μg/ml) increased the intracellular accumulation of doxorubicin in KB/MDR cells by about two- to threefold but not in KB parent cells. Monensin also markedly reduced doxorubicin efflux from KB/MDR cells. Under the same conditions, monensin enhanced the cellular uptake and cytotoxicity of daunorubicin and hydroxyrubicin in KB/MDR cells but not of the lipophilic anthracycline annamycin. By alkaline elution technique, monensin (5 μg/ml) alone did not induce DNA damage in either KB parent or KB/MDR cells after 1 h of incubation and did not enhance doxorubicin-induced DNA damage in KB parent cells, whereas it significantly increased doxorubicin induced DNA double-strand breaks in KB/MDR cells. Our results indicate that reversal of MDR by monensin may be due to facilitation of drug transport and subsequent enhancement of DNA damage in MDR cells.",
author = "Ling, {Y. H.} and W. Priebe and Roman Perez-Soler",
year = "1993",
language = "English (US)",
volume = "3",
pages = "971--977",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "5",

}

TY - JOUR

T1 - Intrinsic cytotoxicity and reversal of multidrug-resistance by monensin in KB parent and MDR cells

AU - Ling, Y. H.

AU - Priebe, W.

AU - Perez-Soler, Roman

PY - 1993

Y1 - 1993

N2 - Results presented in this study indicate that monensin, a Na+/H+ gradient ionophore, is by itself a potent inhibitor of proliferation of both KB parent and KB/multidrug resistant (MDR) cells. By MTT assay, the ID50 of monensin against both cell lines after a 72 h drug exposure was 0.2±0.04 μg/ml. Following a 1 h exposure of KB parent and KB/MDR cells to 0.1-10 μg/ml- monensin, [3H]thymidine, [3H]uridine, [3H]leucine incorporation into DNA, RNA, and proteins, respectively, was not inhibited, thus suggesting that the mechanism of cytotoxicity of monensin may not be mediated by a direct effect on macromolecular synthesis. In the presence of subtoxic concentrations of monensin (0.05-0.1 μg/ml), the ID50 of doxorubicin against KB/MDR cells after a 72 h drug exposure was reduced from >100 μg/ml to 45 and 18 μg/ml, respectively, while the presence of monensin did not significantly alter doxorubicin cytotoxicity against KB parent cells. In 1 h experiments, the presence of monensin (5 μg/ml) increased the intracellular accumulation of doxorubicin in KB/MDR cells by about two- to threefold but not in KB parent cells. Monensin also markedly reduced doxorubicin efflux from KB/MDR cells. Under the same conditions, monensin enhanced the cellular uptake and cytotoxicity of daunorubicin and hydroxyrubicin in KB/MDR cells but not of the lipophilic anthracycline annamycin. By alkaline elution technique, monensin (5 μg/ml) alone did not induce DNA damage in either KB parent or KB/MDR cells after 1 h of incubation and did not enhance doxorubicin-induced DNA damage in KB parent cells, whereas it significantly increased doxorubicin induced DNA double-strand breaks in KB/MDR cells. Our results indicate that reversal of MDR by monensin may be due to facilitation of drug transport and subsequent enhancement of DNA damage in MDR cells.

AB - Results presented in this study indicate that monensin, a Na+/H+ gradient ionophore, is by itself a potent inhibitor of proliferation of both KB parent and KB/multidrug resistant (MDR) cells. By MTT assay, the ID50 of monensin against both cell lines after a 72 h drug exposure was 0.2±0.04 μg/ml. Following a 1 h exposure of KB parent and KB/MDR cells to 0.1-10 μg/ml- monensin, [3H]thymidine, [3H]uridine, [3H]leucine incorporation into DNA, RNA, and proteins, respectively, was not inhibited, thus suggesting that the mechanism of cytotoxicity of monensin may not be mediated by a direct effect on macromolecular synthesis. In the presence of subtoxic concentrations of monensin (0.05-0.1 μg/ml), the ID50 of doxorubicin against KB/MDR cells after a 72 h drug exposure was reduced from >100 μg/ml to 45 and 18 μg/ml, respectively, while the presence of monensin did not significantly alter doxorubicin cytotoxicity against KB parent cells. In 1 h experiments, the presence of monensin (5 μg/ml) increased the intracellular accumulation of doxorubicin in KB/MDR cells by about two- to threefold but not in KB parent cells. Monensin also markedly reduced doxorubicin efflux from KB/MDR cells. Under the same conditions, monensin enhanced the cellular uptake and cytotoxicity of daunorubicin and hydroxyrubicin in KB/MDR cells but not of the lipophilic anthracycline annamycin. By alkaline elution technique, monensin (5 μg/ml) alone did not induce DNA damage in either KB parent or KB/MDR cells after 1 h of incubation and did not enhance doxorubicin-induced DNA damage in KB parent cells, whereas it significantly increased doxorubicin induced DNA double-strand breaks in KB/MDR cells. Our results indicate that reversal of MDR by monensin may be due to facilitation of drug transport and subsequent enhancement of DNA damage in MDR cells.

UR - http://www.scopus.com/inward/record.url?scp=0027367788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027367788&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0027367788

VL - 3

SP - 971

EP - 977

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 5

ER -